查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864170

治療性低溫系統市場按產品類型、冷卻方式、應用、最終用戶和溫度控制類型分類－2025-2032年全球預測

Therapeutic Hypothermia Systems Market by Product Type, Cooling Method, Application, End User, Temperature Control Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，治療性低溫系統市場將成長至 5.5196 億美元，複合年成長率為 6.91%。

關鍵市場統計數據
基準年 2024 3.2331億美元
預計年份：2025年 3.4529億美元
預測年份 2032 5.5196億美元
複合年成長率 (%) 6.91%

這篇引人入勝的引言闡述了臨床預期、技術進步和營運需求如何融合，共同塑造治療性低溫系統的未來。

治療性低溫系統在加護治療創新和實證臨床通訊協定的交會點發揮著至關重要的作用。過去十年，臨床界已普遍支持將目標溫度管理（TTM）作為某些神經系統疾病和復甦後適應症的基石干預措施。這促使醫療設備製造商和醫院技術團隊優先考慮更安全、更精準的降溫方法。在此背景下，相關人員努力應對日益複雜的局面，臨床療效、操作便捷性、與醫院工作流程的整合以及監管政策的清晰度等因素將決定其推廣應用的進展。

臨床醫生現在期望醫療設備能夠提供精確的溫度控制，快速達到治療目標，並最大限度地減少對其他同期手術的干擾。同時，技術創新和材料科學的進步催生了創傷較小的表面冷卻方案和先進的血管內導管，每種方案都有其獨特的臨床優缺點。此外，醫療系統面臨著透過改善患者預後和簡化診療流程來證明其價值的壓力，因此，醫療設備的選擇決策不再由單一的採購部門做出，而是由多學科委員會共同製定。最終，採購決策將基於臨床數據對比、與溫度監測系統的兼容性以及長期可維護性等因素。

展望未來，互通平台的普及和多中心臨床項目證據的不斷改進將繼續影響採購標準。標準、報銷政策和臨床醫生培訓方面的過渡性發展可能會凸顯全面實施計劃的重要性。因此，決策者必須仔細權衡臨床效益和營運影響，以確保設備應用能夠帶來可衡量的臨床改善。

不斷發展的臨床證據、醫療設備創新和醫院營運重點如何重塑治療性低溫系統的採購和部署

治療性低溫療法領域經歷了許多變革，這些變革的驅動力包括臨床證據、醫療設備創新和系統層面的迫切需求。首先，臨床實踐已從廣泛應用轉向基於隨機對照試驗和更細緻的指南更新的、更有針對性的體溫管理，這些指南更新強調患者選擇和治療時機。這種臨床實踐的精細化提高了醫療設備性能的標準；精確性、快速指導和可控復溫已成為核心差異化因素。

其次，技術進步拓展了器械的套件。導管設計、熱交換效率和表面冷卻材料的改進，使得器械能夠應用於更廣泛的臨床場景，並降低手術風險。同時，數位化整合，例如電子病歷整合和遠端監測功能，正在逐步提高工作流程效率，並加強對通訊協定的遵循。這些能力正在改變採購討論的焦點，使人們的關注點從單一裝置的功能轉向平台層面的相容性和全生命週期服務。

第三，醫院內部的營運現實，例如重症監護室容量限制和對感染預防日益重視，正在加速人們對微創模組化降溫解決方案的興趣。醫院正日益評估治療性低溫系統如何融入更廣泛的醫療計畫中，例如復甦、加護治療和手術全期管理。因此，臨床醫生、生物醫學工程團隊和供應鏈負責人之間的合作變得更加策略性，除了整體擁有成本和實施支持外，還強調臨床效益的證據。這些變化正在共同重塑產業相關人員和臨床採用者的預期。

評估受2025年關稅調整影響的製造商和醫療保健提供者的短期供應鏈調整和策略採購轉變

2025年公佈的關稅調整為醫療設備製造商、分銷網路和醫療保健系統帶來了新的複雜性，影響了跨境供應鏈和籌資策略。為此，製造商重新評估了製造地、籌資策略和定價模式，以在應對利潤壓力的同時維持供應的連續性。對於醫院和採購聯盟而言，眼前的挑戰是重新評估競標規範並加強本地庫存緩衝，以緩解潛在的前置作業時間波動。

這些變化正推動近期商業性結構調整以降低關稅風險，包括重新談判分銷合約以及擴大區域組裝和最終配置中心的使用。同時，醫療設備開發商正加強實現關鍵零件（例如導熱介面材料和電子元件）的在地採購或尋找替代供應商。在營運方面，臨床團隊和採購負責人越來越關注總落地成本和物流風險，並將關稅風險納入多年資本規劃。

從中長期來看，關稅環境促使相關人員探索創造性的合約方式，包括基於價值的採購協議和聯合採購，以充分利用規模經濟。此外，人們也更加關注旨在延長設備使用壽命和抵消資本支出的服務協議和再製造項目。最終，儘管關稅造成了短期摩擦，但也加速了圍繞近岸外包、庫存彈性以及採購多元化等戰略議題的討論，從長遠來看，這有可能加強供應鏈。

深度細分分析揭示了產品類型、冷卻方式、臨床應用、最終用戶和溫度控制方法如何驅動差異化的設備策略和臨床應用。

細分市場分析揭示了治療性低溫領域中不同的應用模式和產品策略，反映了不同的臨床需求和操作限制。產品類型差異涵蓋頻譜廣泛，從毯子和墊片系統到水循環系統、冰袋和凝膠袋，其中基於導管的系統在侵入性靶向降溫領域佔據重要地位。在基於導管的降溫方法中，球囊導管和液體導管的插入方式和熱交換機制各不相同，這會影響在嚴重監護環境下臨床醫生的選擇。

在降溫方法領域，血管內降溫與體表降溫之間存在明顯的技術差異。血管內裝置能夠直接調節核心體溫，而體表降溫方法，例如毯式降溫系統、冰袋/凝膠袋、墊片降溫系統和水循環系統，則提供了非侵入性的選擇，可以輕鬆整合到現有的工作流程中。按應用領域分類，突顯了推動需求的臨床應用場景。雖然心臟麻痹和新生兒腦病變仍然是體溫管理的重點場景，但術後護理、中風和創傷性腦損傷等領域也在不斷評估低溫通訊協定在神經保護和最佳化復健方面的應用。

終端使用者細分突顯了實施複雜性和採購權限的差異：門診中心、居家醫療機構、醫院和專科診所，每個機構的營運能力和臨床人員配備各不相同。溫度控制類型細分突顯了受控溫度管理和非受控冷卻之間的區別，前者進一步細分為目標性低溫和目標常溫策略，這兩種策略需要不同的設備控制粒度和警報管理。總而言之，這些細分觀點突顯了臨床適應症、護理環境和首選冷卻方式如何相互作用，從而決定設備的選擇和商業化策略。

從區域比較的觀點來看，不同的監管、臨床和供應鏈趨勢正在塑造美洲、歐洲/中東/非洲和亞太地區的醫療器材採用路徑。

區域趨勢涵蓋美洲、歐洲、中東和非洲以及亞太地區，各地區有不同的促進因素，影響醫療器材的普及、報銷和供應鏈策略。在美洲，先進的加護治療基礎設施和一體化的採購網路促進了高成本精密醫療設備的快速普及。區域性復甦後護理卓越中心通常在實證實踐的生成和最佳實踐的推廣方面主導。因此，採購流程通常會納入臨床結果數據，並且需要完善的服務和培訓系統來支援大型醫院系統的應用。

同時，歐洲、中東和非洲地區各市場的法規結構和報銷途徑差異顯著，影響商業化策略。許多歐洲、中東和非洲國家的公共醫療採購強調長期價值和互通性，要求製造商證明其產品能夠整合工作流程並提供永續的服務計劃。此外，區域臨床協會和合作研究網路在製定指南醫療器材選擇的指南方面也發揮著重要作用。

在亞太地區，急診護理能力的快速提升，以及對新生兒和加護治療服務投入的增加，催生了對擴充性、具成本效益降溫解決方案的強勁需求。供應鏈本地化和區域夥伴關係正被廣泛用於縮短前置作業時間，並使定價模式適應不同的市場細分。在整個亞太地區，跨國臨床研究合作和共用註冊庫正在促進建立更一致的證據標準，進而支持最佳實踐和技術的廣泛傳播。

對治療性低溫療法公司的競爭原型、策略重點與夥伴關係模式進行客觀檢驗，以界定其競爭與合作格局。

治療性低溫領域的競爭動態凸顯了產業參與者的三種策略類型：大型多元化醫療設備公司憑藉其規模和服務網路優勢；專注於核心冷卻技術的專業設備製造商；以及推動材料和軟體創新的敏捷型Start-Ups。大型公司往往能夠贏得企業級契約，優先考慮與醫院基礎設施的無縫整合、全面的培訓計劃和完善的售後服務支援。它們也重視合規性和全球分銷，從而能夠進行廣泛的臨床試驗和多市場部署。

專業製造商專注於改善熱交換效率、導管設計和表面冷卻的人體工學，瞄準臨床細分市場，在這些市場中，技術性能的提升能夠轉化為可衡量的治療效果改善。這些公司通常與領先的臨床中心密切合作，以檢驗設備療效並完善通訊協定。同時，Start-Ups更傾向於推出顛覆性概念，例如創新熱交換材料、用於混合冷卻策略的模組化系統以及提供先進自動化和分析功能的溫度管理軟體驅動控制系統。

在這些典型案例中，策略重點都集中在可證實的臨床效益、具有成本效益的服務模式以及透過品質系統和監管途徑進行風險管理等方面。醫療器材公司與臨床網路之間的夥伴關係，以及租賃、翻新和按績效付費合約等創造性商業模式，正被擴大用於推動產品應用，並將商業性獎勵與臨床結果相結合。

為製造商和醫療保健領導者提供切實有效的建議，以促進安全應用、增強供應鏈韌性並展示治療性低溫的臨床價值。

行業領導者應促進協作，在臨床療效、操作適用性和財務永續性之間取得平衡，以擴大產品應用範圍並改善患者預後。首先，製造商應優先考慮互通性和以臨床醫生為中心的設計，確保設備能夠與監測平台和電子健康記錄系統整合，從而減輕認知負荷並提高通訊協定的依從性。投資於模組化產品架構和可擴展的培訓項目，能夠針對不同的醫療環境進行快速客製化，從而加快產品部署後發揮臨床作用的速度。

第二，相關人員應透過多中心註冊研究及反映真實臨床實務的實用性研究，深化臨床證據的累積。此類證據將有助於在療效有爭議的適應症中推廣應用，並為支付方和採購委員會評估長期價值提供參考。第三，應採取零件供應商多元化和區域組裝策略，以降低關稅和運輸風險，並增強供應鏈韌性。諸如按績效付費合約和服務捆綁定價等合約創新，可以協調醫療服務提供者和供應商之間的獎勵，並有助於提高高效能系統的可及性。

最後，醫療系統和供應商應攜手合作，制定一套標準化的實施套件，其中包括訓練課程、通訊協定範本和審核機制。這些資源將減少臨床實踐中的差異，並加速安全、一致的實施。透過將技術改進與營運支援和實證實踐相結合，行業領導者可以將治療性低溫系統定位為加護治療路徑中值得信賴且影響深遠的組成部分。

採用透明的混合方法調查方法，結合臨床醫師訪談、技術評估和供應鏈分析，確保獲得可靠且可操作的見解。

本調查方法採用混合方法，對臨床實務模式、技術趨勢和供應鏈趨勢進行三角驗證。主要數據透過臨床主任、醫療設備工程師、採購負責人和產品經理的結構化訪談收集，並輔以在典型臨床環境中對裝置應用的觀察評估。次要資料包括同儕審查的臨床文獻、監管申報文件、器械使用說明書和技術白皮書（其中定義了器械的運行原理和性能特徵）。

我們的分析方法包括對訪談記錄進行定性編碼，以識別實施過程中遇到的挑戰和優先主題，以及進行技術比較評估，以評估設備的功能特性和控制能力。我們的供應鏈分析檢驗了關稅措施、公開的進出口數據以及製造商關於製造地搬遷和分銷商協議的公告。在整個過程中，我們透過交叉引用獨立資訊來源並與關鍵知情人士核實，進行合理性檢驗，以減少偏見並確保事實準確性。

報告明確指出了其局限性，包括臨床實踐的區域差異以及特定應用領域證據的不斷演變。在適用情況下，報告透過敏感性分析對建議進行了仔細調整，以確保其在各種不同的營運和監管環境下仍然有效。

總結結論認為，臨床整合、實施的嚴謹性和策略性商業化是治療性低溫領域成功的關鍵因素。

總之，治療性低溫系統正處於策略轉折點，臨床成熟度、技術創新和營運需求在此交會融合。該領域未來的發展軌跡不僅取決於設備本身的性能，還取決於製造商和醫療系統能否將該技術整合到診療路徑中、產生真實世界證據並應對複雜的供應鏈。那些能夠使產品設計與臨床醫生工作流程相契合、加強實施支持並積極參與協作式證據生成的機構，將更有可能取得成功。

在營運層面，採用系統化方法（包括規範通訊協定、員工培訓和實施後審核）的醫院更有可能獲得持續的臨床效益。在商業層面，注重互通性、服務可靠性和彈性合約的供應商將贏得高層採購委員會的支持。最後，政策和報銷的清晰度將成為關鍵促進因素，因為支付方認知到改善神經系統疾病預後和減少長期照護需求的潛力。在這些關鍵的相互關聯問題上採取果斷行動的相關人員將更有利於把前景廣闊的技術轉化為患者照護可衡量的改進。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合自動溫度控制和即時病患監測，以提高神經保護的準確性
  • 開發攜帶式穿戴式治療性低溫設備，用於院外緊急醫療環境
  • 利用尖端材料進行非侵入性冷卻技術，實現目標器官保存
  • 新興的AI驅動通訊協定可根據個別患者的代謝特徵最佳化冷卻速率。
  • 擴大全球報銷框架，以支持心臟麻痹後護理中的治療性低溫療法
  • 一項評估聯合藥物治療和低溫療法協同神經保護作用的臨床試驗
  • 醫療設備製造商與醫療保健系統建立策略聯盟，以簡化低溫療法的輸送流程

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的治療性低溫系統市場

  • 毛毯系統
  • 基於導管的系統
    • 球囊導管
    • 液態導管
  • 冰袋和凝膠袋
  • 墊片系統
  • 水循環系統

9. 依冷卻方式分類的治療性低溫系統市場

  • 血管內冷卻
  • 表面冷卻
    • 毛毯系統
    • 冰袋和凝膠袋
    • 墊片系統
    • 水循環系統

第10章 按應用分類的治療性低溫系統市場

  • 心臟麻痹
  • 新生兒腦病變
  • 術後
  • 中風
  • 創傷性腦損傷

第11章 以最終用戶分類的治療性低溫系統市場

  • 門診治療中心
  • 居家醫療環境
  • 醫院
  • 專科診所

第12章 依溫度控制類型分類的治療性低溫系統市場

  • 溫度控制
    • 標靶低溫療法
    • 有針對性的正常體溫管理
  • 不受控制的冷卻

13. 各地區治療性低溫療法系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 治療性低溫系統市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國治療性低溫療法系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Stryker Corporation
    • CR Bard, Inc.
    • ZOLL Medical Corporation
    • B. Braun Melsungen AG
    • Dragerwerk AG & Co. KGaA
    • Koninklijke Philips NV
    • Fisher & Paykel Healthcare Corporation Limited
    • Haemonetics Corporation
    • Arizant Healthcare Inc.
    • Cincinnati Sub-Zero Products, Inc.
Product Code: MRR-647F3A880AF7

The Therapeutic Hypothermia Systems Market is projected to grow by USD 551.96 million at a CAGR of 6.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 323.31 million
Estimated Year [2025] USD 345.29 million
Forecast Year [2032] USD 551.96 million
CAGR (%) 6.91%

A high-impact introduction framing how clinical expectations, engineering advances, and healthcare operational imperatives together shape the future of therapeutic hypothermia systems

Therapeutic hypothermia systems occupy a pivotal role at the intersection of critical care innovation and evidence-based clinical protocols. Over the past decade, the clinical community has coalesced around targeted temperature management as a cornerstone intervention for select neurological and post-resuscitation indications, prompting device manufacturers and hospital technology teams to prioritize safer, more precise cooling modalities. Against this backdrop, stakeholders are navigating an increasingly complex landscape where clinical efficacy, ease of use, integration with hospital workflows, and regulatory clarity determine adoption trajectories.

Clinicians now expect devices to offer precise temperature control, rapid attainment of therapeutic targets, and minimal interference with concurrent interventions. At the same time, engineering advances and materials science have enabled less invasive surface cooling options and more sophisticated intravascular catheters, each with distinct clinical trade-offs. In parallel, health systems face pressure to demonstrate value through improved patient outcomes and streamlined care pathways, which places device selection squarely in the domain of multidisciplinary committees rather than singular buyer groups. Consequently, purchasing decisions hinge on comparative clinical data, compatibility with temperature monitoring systems, and long-term serviceability.

Looking ahead, the introduction of interoperable platforms and the maturation of evidence from multicenter clinical programs will continue to shape procurement criteria. Transitional developments in standards, reimbursement policy, and clinician training are likely to amplify the importance of comprehensive implementation planning. Therefore, decision-makers must weigh clinical benefits alongside operational impacts to ensure that device adoption translates into measurable improvements at the bedside.

How evolving clinical evidence, device innovation, and hospital operational priorities are collectively reshaping procurement and deployment of therapeutic hypothermia systems

The therapeutic hypothermia landscape has experienced several transformative shifts driven by clinical evidence, device innovation, and systems-level imperatives. First, clinical practice has moved from broad application toward increasingly targeted temperature management, informed by randomized trials and nuanced guideline updates that emphasize patient selection and timing. This clinical refinement has raised the bar for device performance: precision, rapid induction, and controlled rewarming have become core differentiators.

Second, technological progress has expanded the device toolkit. Improvements in catheter design, thermal exchange efficiency, and surface cooling materials have enabled a broader set of clinical scenarios to be addressed with lower procedural risk. Concurrently, digital integration-such as connectivity with electronic health records and remote monitoring capabilities-has begun to unlock workflow efficiencies and enable better adherence to protocols. These capabilities have altered procurement conversations, shifting focus from standalone device features to platform-level compatibility and lifecycle services.

Third, operational realities within hospitals, including constrained ICU capacity and heightened attention to infection prevention, have accelerated interest in less invasive and more modular cooling solutions. Hospitals are increasingly evaluating how hypothermia systems align with broader programs in resuscitation, neurocritical care, and perioperative management. As a result, partnerships between clinicians, biomedical engineering teams, and supply chain leaders have become more strategic, emphasizing evidence of clinical benefit alongside total cost of ownership and implementation support. Together, these shifts have recalibrated expectations for industry participants and clinical adopters alike.

An assessment of how 2025 tariff adjustments prompted near-term supply chain adaptations and strategic procurement shifts across manufacturers and healthcare providers

Tariff changes announced in 2025 have introduced a new layer of complexity for device manufacturers, distributor networks, and health systems, affecting cross-border supply chains and procurement strategies. In response, manufacturers have reassessed manufacturing footprints, sourcing strategies, and pricing models to preserve supply continuity while managing margin pressure. For hospitals and purchasing consortia, the immediate imperative has been to re-evaluate tender specifications and to strengthen local inventory buffers to mitigate potential lead-time variability.

These changes have prompted near-term commercial realignments such as renegotiated distribution agreements and increased use of regional assembly or final configuration centers to reduce tariff exposure. At the same time, device developers have intensified efforts to localize key components and to secure alternative suppliers for thermally conductive materials and electronics. From an operational perspective, clinical teams and procurement professionals have increased scrutiny of total landed cost and logistics risk, and they now factor tariff volatility into multi-year capital planning.

In the medium term, the tariff environment has encouraged stakeholders to explore creative contracting approaches, including value-based procurement arrangements and consortia purchasing that leverage scale. Additionally, there is growing emphasis on service contracts and refurbishment programs to extend device life cycles and offset capital expenditures. Ultimately, while tariffs have introduced short-term friction, they have also accelerated strategic conversations around nearshoring, inventory resilience, and diversified sourcing that may strengthen supply chains over time.

Deep segmentation analysis illuminating how product types, cooling modalities, clinical applications, end users, and temperature control approaches drive differentiated device strategies and clinical adoption

Segmentation insights reveal differentiated adoption patterns and product strategies across the therapeutic hypothermia landscape, reflecting distinct clinical needs and operational constraints. Product type differentiation captures a spectrum from blanket systems and pad systems to water circulation systems and ice or gel packs, with catheter-based systems occupying a critical niche for invasive targeted cooling. Within catheter-based approaches, balloon-based catheters and fluid-based catheters present different insertion profiles and heat-exchange mechanics that influence clinician preference in high-acuity settings.

Cooling method segmentation draws a clear technical divide between intravascular cooling and surface cooling, where intravascular devices offer direct core temperature modulation and surface approaches-embodied by blanket systems, ice packs and gel packs, pad systems, and water circulation systems-provide noninvasive alternatives that integrate readily into existing workflows. Application-focused segmentation maps the clinical use cases that drive demand: cardiac arrest and neonatal encephalopathy remain high-priority scenarios for targeted temperature management, while post-surgical care, stroke, and traumatic brain injury represent growing areas where hypothermia protocols are evaluated for neuroprotection and recovery optimization.

End-user segmentation highlights where implementation complexity and purchasing authority diverge, spanning ambulatory care centers, homecare settings, hospitals, and specialty clinics, each with distinctive operational capabilities and clinical staffing models. Temperature control type segmentation draws attention to controlled temperature management versus uncontrolled cooling, with the former further refined into targeted hypothermia and targeted normothermia strategies that require different device control fidelity and alarm management. Taken together, these segmentation lenses underscore that clinical indication, care setting, and preferred cooling modality co-determine device selection and commercialization approaches.

A comparative regional perspective showing how distinct regulatory, clinical, and supply chain dynamics in the Americas, Europe Middle East & Africa, and Asia-Pacific shape device adoption pathways

Regional dynamics exhibit distinct drivers that influence adoption, reimbursement, and supply chain strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced critical care infrastructure and consolidated purchasing networks enable quicker uptake of higher-cost precision devices, while regional centers of excellence for post-resuscitation care often lead evidence generation and best-practice dissemination. Consequently, procurement cycles frequently incorporate clinical outcomes data and require robust service and training offerings to support deployment across sprawling hospital systems.

Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks and reimbursement pathways vary considerably between markets, which in turn affects the commercialization approach. In many EMEA countries, public healthcare procurement emphasizes long-term value and interoperability, prompting manufacturers to demonstrate workflow integration and durable service plans. Additionally, regional clinical societies and collaborative research networks play a pivotal role in shaping guidelines that inform device selection.

In the Asia-Pacific region, rapid expansion of acute care capacity, coupled with increasing investment in neonatal and neurocritical services, has created strong demand for scalable, cost-effective cooling solutions. Supply chain localization and regional partnerships are commonly used to reduce lead times and adapt pricing models to diverse market segments. Across all regions, cross-border collaboration on clinical studies and shared registries is fostering more consistent evidence standards, which supports broader diffusion of best practices and technologies.

A clear-eyed examination of competitive archetypes, strategic priorities, and partnership models that define how companies compete and collaborate in therapeutic hypothermia

Competitive dynamics in therapeutic hypothermia underscore three strategic archetypes among industry participants: large diversified medical device firms leveraging scale and service networks, specialized device manufacturers focused on core cooling technologies, and agile startups driving material or software innovations. Large firms tend to prioritize seamless integration with hospital infrastructure, comprehensive training programs, and extensive post-sales support to win enterprise-level contracts. They also place emphasis on regulatory compliance and global distribution, enabling broad clinical trials and multi-market rollouts.

Specialized manufacturers concentrate on iterative improvements to thermal exchange efficiency, catheter design, or surface cooling ergonomics, targeting clinical niches where technical performance can yield measurable outcome improvements. These companies often collaborate closely with leading clinical centers to validate device efficacy and refine protocols. Meanwhile, startups are more likely to introduce disruptive concepts such as novel heat-exchange materials, modular systems for hybrid cooling strategies, or software-driven control systems that deliver advanced automation and analytics for temperature management.

Across these archetypes, strategic priorities converge on demonstrable clinical benefit, cost-effective service models, and managed risk through quality systems and regulatory pathways. Partnerships between device firms and clinical networks, along with creative commercial models such as leasing, refurbishment, and outcome-linked contracts, are increasingly used to accelerate adoption and to align commercial incentives with clinical outcomes.

Actionable, high-impact recommendations for manufacturers and healthcare leaders to accelerate safe adoption, strengthen supply resilience, and demonstrate clinical value in therapeutic hypothermia

Industry leaders should pursue a coordinated agenda that balances clinical efficacy, operational fit, and financial sustainability to expand adoption and improve patient outcomes. First, manufacturers must prioritize interoperability and clinician-centered design by ensuring devices integrate with monitoring platforms and electronic health records, thereby reducing cognitive load and enhancing protocol adherence. Investing in modular product architectures and scalable training programs will enable rapid customization for different care settings and improve time-to-clinical-impact during rollouts.

Second, stakeholders should deepen clinical evidence generation through multicenter registries and pragmatic studies that reflect real-world practice. Such evidence will support adoption in indications where benefit remains debated and will inform payers and procurement committees evaluating long-term value. Third, supply chain resilience must be reinforced by diversifying component suppliers and adopting regional assembly strategies to mitigate tariff and transportation risks. Contract innovations such as outcome-linked agreements and service-inclusive pricing can align incentives across providers and vendors, making high-performance systems more accessible.

Finally, health systems and vendors should collaborate to create standardized implementation toolkits that include training curricula, protocol templates, and audit mechanisms. These resources will reduce variability in clinical practice and accelerate safe, consistent deployment. By combining technological refinement with operational support and evidence generation, industry leaders can position therapeutic hypothermia systems as reliable, high-impact elements of critical care pathways.

A transparent mixed-methods research approach combining clinician interviews, technical assessments, and supply chain analysis to ensure robust and actionable insights

The research methodology applied a mixed-methods approach designed to triangulate clinical practice patterns, technology trends, and supply chain developments. Primary data inputs were gathered through structured interviews with clinical leads, biomedical engineers, procurement officers, and product managers, supplemented by observational assessments of device deployment in representative care settings. Secondary inputs included peer-reviewed clinical literature, regulatory filings, device instructions for use, and technical white papers that elucidate device operating principles and performance characteristics.

Analytical techniques included qualitative coding of interview transcripts to surface recurring implementation challenges and thematic priorities, alongside comparative technical assessments to evaluate device feature sets and control capabilities. Supply chain analysis incorporated review of tariff measures, public import/export data, and observed manufacturer announcements related to manufacturing shifts or distributor agreements. Throughout the process, validity checks were applied via cross-referencing of independent sources and follow-up clarifications with key informants to mitigate bias and ensure factual accuracy.

Limitations were explicitly acknowledged, including variability in regional clinical practice and the evolving nature of evidence in certain applications. Where applicable, recommendations were tempered by sensitivity analyses and were framed to remain relevant across a range of operational and regulatory scenarios.

A decisive conclusion synthesizing how clinical integration, implementation rigor, and strategic commercialization will determine who succeeds in the therapeutic hypothermia arena

In conclusion, therapeutic hypothermia systems stand at a strategic inflection point where clinical maturation, engineering innovation, and operational demands intersect. The future trajectory of the field will be determined not only by device-level performance but by the ability of manufacturers and health systems to integrate technology into care pathways, to generate real-world evidence, and to manage supply chain complexity. Success will favor organizations that align product design with clinician workflows, bolster implementation support, and engage in collaborative evidence generation.

Operationally, hospitals that adopt a programmatic approach-combining protocol standardization, staff training, and post-implementation auditing-are more likely to realize consistent clinical benefits. Commercially, vendors that emphasize interoperability, service reliability, and flexible contracting will resonate with sophisticated procurement committees. Finally, policy and reimbursement clarity will be a critical accelerant where payers recognize the potential for improved neurological outcomes and reduced long-term care needs. Stakeholders that act decisively on these interrelated imperatives will be well placed to turn promising technology into measurable improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of automated temperature control with real-time patient monitoring to enhance precision in neuroprotection
  • 5.2. Development of portable and wearable hypothermia devices for prehospital emergency care implementation
  • 5.3. Adoption of noninvasive cooling technologies leveraging advanced materials for targeted organ preservation
  • 5.4. Emergence of AI-driven protocols optimizing cooling rates based on individual patient metabolic profiles
  • 5.5. Expansion of global reimbursement frameworks supporting therapeutic hypothermia in post-cardiac arrest care
  • 5.6. Clinical trials assessing combined pharmacologic interventions and hypothermia for enhanced neuroprotective synergy
  • 5.7. Strategic partnerships between device manufacturers and healthcare systems for streamlined hypothermia therapy deployment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Therapeutic Hypothermia Systems Market, by Product Type

  • 8.1. Blanket Systems
  • 8.2. Catheter-Based Systems
    • 8.2.1. Balloon-Based Catheters
    • 8.2.2. Fluid-Based Catheters
  • 8.3. Ice Packs & Gel Packs
  • 8.4. Pad Systems
  • 8.5. Water Circulation Systems

9. Therapeutic Hypothermia Systems Market, by Cooling Method

  • 9.1. Intravascular Cooling
  • 9.2. Surface Cooling
    • 9.2.1. Blanket Systems
    • 9.2.2. Ice Packs & Gel Packs
    • 9.2.3. Pad Systems
    • 9.2.4. Water Circulation Systems

10. Therapeutic Hypothermia Systems Market, by Application

  • 10.1. Cardiac Arrest
  • 10.2. Neonatal Encephalopathy
  • 10.3. Post Surgery
  • 10.4. Stroke
  • 10.5. Traumatic Brain Injury

11. Therapeutic Hypothermia Systems Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Homecare Settings
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Therapeutic Hypothermia Systems Market, by Temperature Control Type

  • 12.1. Controlled Temperature Management
    • 12.1.1. Targeted Hypothermia
    • 12.1.2. Targeted Normothermia
  • 12.2. Uncontrolled Cooling

13. Therapeutic Hypothermia Systems Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Therapeutic Hypothermia Systems Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Therapeutic Hypothermia Systems Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Stryker Corporation
    • 16.3.2. C.R. Bard, Inc.
    • 16.3.3. ZOLL Medical Corporation
    • 16.3.4. B. Braun Melsungen AG
    • 16.3.5. Dragerwerk AG & Co. KGaA
    • 16.3.6. Koninklijke Philips N.V.
    • 16.3.7. Fisher & Paykel Healthcare Corporation Limited
    • 16.3.8. Haemonetics Corporation
    • 16.3.9. Arizant Healthcare Inc.
    • 16.3.10. Cincinnati Sub-Zero Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)

TABLE